BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7739851)

  • 1. [Diagnostic value of the study of caffeine elimination in chronic liver diseases].
    Darnót G; Nemesánszky E; Bariska J
    Orv Hetil; 1995 Apr; 136(18):927-32. PubMed ID: 7739851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
    Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.
    Hartleb M; Romańczyk T; Becker A; Mańczyk I; Waluga M; Spalińska M; Zieliński M
    Ital J Gastroenterol; 1992; 24(6):332-7. PubMed ID: 1515659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of an enzyme-multiplied immunoassay technique for determination of caffeine elimination kinetics as a test of liver function in clinically normal dogs.
    Golden DL; Spano JS; Wilson RC; DeGraves FJ; Whatley EM
    Am J Vet Res; 1994 Jun; 55(6):790-4. PubMed ID: 7944016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites.
    Tanaka E; Ishikawa A; Yamamoto Y; Osada A; Tsuji K; Fukao K; Misawa S; Iwasaki Y
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):336-41. PubMed ID: 1428297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of liver disease on urine caffeine metabolite ratios.
    Denaro CP; Wilson M; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1996 Jun; 59(6):624-35. PubMed ID: 8681487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
    Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR
    J Clin Invest; 1975 Feb; 55(2):347-59. PubMed ID: 1127104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Caffeine blood concentration as an indicator of liver damage in patients with cirrhosis--correlation with Child's classification].
    Habior A
    Wiad Lek; 1990 May 1-15; 43(9-10):412-6. PubMed ID: 2219928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.
    Wensing G; Hoffmann K; Heidemann HT
    Z Gastroenterol; 1993 Jan; 31(1):15-9. PubMed ID: 8447150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine clearance study in hepatocellular carcinoma.
    Tangkijvanich P; Wittayalertpanya S; Kusonsolboon T; Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 1999 Mar; 82(3):297-303. PubMed ID: 10410486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function.
    Park GJ; Katelaris PH; Jones DB; Seow F; Le Couteur DG; Ngu MC
    Hepatology; 2003 Nov; 38(5):1227-36. PubMed ID: 14578861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of caffeine elimination and Child's classification in liver cirrhosis.
    Holstege A; Staiger M; Haag K; Gerok W
    Klin Wochenschr; 1989 Jan; 67(1):6-15. PubMed ID: 2921843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis?
    Abbasi A; Bhutto AR; Butt N; Lal K; Munir SM
    J Coll Physicians Surg Pak; 2012 Aug; 22(8):484-7. PubMed ID: 22868011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of gamma glutamyl transpeptidase and the mean corpuscular volume in chronic hepatitis of alcoholic etiology].
    Pasqualetti P; Festuccia V; MacCarone C; Di Lauro G; Casale R
    Minerva Med; 1995 Oct; 86(10):395-402. PubMed ID: 8622806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].
    Perlík F; Pucelíková T; Slanar O
    Cas Lek Cesk; 2001 Feb; 140(2):51-3. PubMed ID: 11262908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.
    Kaser S; Moschen A; Kaser A; Ludwiczek O; Ebenbichler CF; Vogel W; Jaschke W; Patsch JR; Tilg H
    J Intern Med; 2005 Sep; 258(3):274-80. PubMed ID: 16115302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.